New therapeutic options in deep vein thrombosis prophylaxis

Seminars in Hematology

Volumn 37, Issue 3 SUPPL. 5, 2000, Pages 7-9

  Eriksson, B I ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DESULFATOHIRUDIN; ENOXAPARIN; HEPARIN; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; PHLEBOGRAPHY; PRIORITY JOURNAL; PROPHYLAXIS; TOTAL HIP PROSTHESIS;

EID: 0033819780     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90093-3     Document Type: Conference Paper

References (8)

1. Prevention of venous thromboembolism. Fourth ACCP Consensus Conference on Anrithrombotic Therapy
2. Reducrion in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin
3. Direct thrombin inhibition with rec-hirudin CGP 39393 as prophylaxis of thomboembolic complications after total hip replacement
4. Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393
5. A comparison of recombinant hirudin with a low molecular weight heparin to prevent thromboembolic complications after total hip replacement
6. A comparison of subcutaneous low molecular weight heparin with warfarin sodium for prophylaxis against deep vein thrombosis after hip or knee implantation
7. Economic evaluation of desirudin vs heparin in deep vein thrombosis prevention after hip replacement surgery
8. Roentgen diagnosis of venous thrombosis in the leg